Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
lxeo
/
Lexeo Therapeutics Inc
LXEO
Add to Watchlist
4.480
USD
-0.180
-3.86%
Close 07-27 16:00(ET)
Quotes delayed by 15 min
4.470
USD
+4.470
After-hours 07/27, 20:00 (ET)
331.89M
Market Cap
Loss
P/E TTM
Lexeo Therapeutics Inc
4.480
-0.180
-3.86%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Suvretta Capital Management, LLC
7.23%
Janus Henderson Investors
7.02%
RA Capital Management, LP
6.37%
Paradigm BioCapital Advisors LP
6.07%
BlackRock Institutional Trust Company, N.A.
5.72%
Other
67.60%
Shareholders
Shareholders
Proportion
Suvretta Capital Management, LLC
7.23%
Janus Henderson Investors
7.02%
RA Capital Management, LP
6.37%
Paradigm BioCapital Advisors LP
6.07%
BlackRock Institutional Trust Company, N.A.
5.72%
Other
67.60%
Shareholder Types
Shareholders
Proportion
Hedge Fund
44.37%
Investment Advisor/Hedge Fund
28.80%
Investment Advisor
15.95%
Venture Capital
11.10%
Private Equity
8.55%
Research Firm
4.34%
Individual Investor
0.61%
Bank and Trust
0.12%
Pension Fund
0.06%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
253
88.41M
112.72%
+15.50M
2025Q4
217
65.42M
89.63%
+10.04M
2025Q3
189
48.60M
66.59%
+5.10M
2025Q2
181
40.60M
122.31%
+231.62K
2025Q1
174
34.46M
103.80%
-3.48M
2024Q4
155
35.40M
107.08%
+416.99K
2024Q3
127
33.64M
101.76%
+2.87M
2024Q2
112
31.41M
96.45%
+1.88M
2024Q1
92
30.30M
97.67%
+5.87M
2023Q4
45
23.22M
87.68%
+3.57M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Janus Henderson Investors
5.51M
7.44%
-595.89K
-9.76%
Dec 31, 2025
RA Capital Management, LP
5.00M
6.75%
--
--
Dec 31, 2025
Paradigm BioCapital Advisors LP
4.76M
6.43%
+1.09M
+29.72%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
4.49M
6.06%
+2.49M
+124.63%
Dec 31, 2025
Vestal Point Capital, LP
4.47M
6.04%
+1.23M
+37.69%
Dec 31, 2025
Frazier Life Sciences Management, L.P.
4.42M
5.97%
--
--
Dec 31, 2025
Affinity Asset Advisors LLC
4.35M
5.87%
+1.15M
+35.95%
Jan 22, 2026
Citadel Advisors LLC
3.77M
5.09%
+55.27K
+1.49%
Dec 31, 2025
Avoro Capital Advisors LLC
3.30M
4.45%
+3.30M
--
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
ProShares Ultra Nasdaq Biotechnology
0.06%
Invesco Nasdaq Biotechnology ETF
0.05%
iShares Micro-Cap ETF
0.05%
iShares Biotechnology ETF
0.04%
iShares Russell 2000 Value ETF
0.02%
Avantis US Small Cap Equity ETF
0.02%
ProShares UltraPro Russell2000
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
View more
ProShares Ultra Nasdaq Biotechnology
Proportion
0.06%
Invesco Nasdaq Biotechnology ETF
Proportion
0.05%
iShares Micro-Cap ETF
Proportion
0.05%
iShares Biotechnology ETF
Proportion
0.04%
iShares Russell 2000 Value ETF
Proportion
0.02%
Avantis US Small Cap Equity ETF
Proportion
0.02%
ProShares UltraPro Russell2000
Proportion
0.01%
Proshares Ultra Russell 2000
Proportion
0.01%
iShares Russell 2000 ETF
Proportion
0.01%
Global X Russell 2000 ETF
Proportion
0.01%